Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Covington
Fuji
Dow
Chinese Patent Office
Boehringer Ingelheim
Cipla
Express Scripts
QuintilesIMS
Baxter

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077708

« Back to Dashboard
NDA 077708 describes CILOSTAZOL, which is a drug marketed by Breckenridge Pharm, Frontida Biopharm, Sandoz, Mylan Pharms Inc, Ivax Sub Teva Pharms, Biokey, Epic Pharma Llc, Mylan, West-ward Pharms Int, Teva, Actavis Elizabeth, Apotex Inc, and Pliva Hrvatska Doo, and is included in sixteen NDAs. It is available from nineteen suppliers. Additional details are available on the CILOSTAZOL profile page.

The generic ingredient in CILOSTAZOL is cilostazol. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cilostazol profile page.

Summary for NDA: 077708

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 077708

Suppliers and Packaging for NDA: 077708

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CILOSTAZOL
cilostazol
TABLET;ORAL 077708 ANDA Breckenridge Pharmaceutical, Inc. 51991-167 51991-167-06 60 TABLET in 1 BOTTLE (51991-167-06)
CILOSTAZOL
cilostazol
TABLET;ORAL 077708 ANDA Breckenridge Pharmaceutical, Inc. 51991-167 51991-167-10 1000 TABLET in 1 BOTTLE (51991-167-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Sep 28, 2009TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Sep 28, 2009TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Harvard Business School
Queensland Health
Cantor Fitzgerald
Chinese Patent Office
Citi
Covington
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot